Background
Methods
Data Source
Study design and population
Measures
Socio-demographic characteristics for index (first) pregnancy
Clinical characteristics
Statistical analysis
Results
Socio-demographic and clinical characteristics
Whole sample N = 456
|
Non-affective psychosis, N = 236
|
Affective SMI, N = 220
|
P*
| |
---|---|---|---|---|
Ethnicity
| ||||
Black African & other Black | 221 (48.5) | 137 (58.1) | 84 (38.2) |
<0.001
|
White British & other White | 152 (33.3) | 58 (24.6) | 94 (42.7) | |
Asian/ Mixed/Other | 83 (18.2) | 41 (17.4) | 42 (19.1) | |
Deprivation score, median (range)
1
| 34.9 (3.8-77.2) | 35.4 (3.8-77.2) | 33.6 (6.8-9.7) | 0.226 |
Maternal age at 1
st
index delivery, mean (SD),
| 31.8 (6.2) | 30.9 (6.4) | 32.9 (5.8) |
<0.001
|
Partner during 1
st
index pregnancy
| ||||
Yes | 299 (68.7) | 143 (63.8) | 156 (73.9) |
0.023
|
No | 136 (31.3) | 81 (36.2) | 55 (26.1) | |
Number of children at 1
st
index pregnancy
| ||||
0 | 197 (44.7) | 101 (43.0) | 96 (46.6) | 0.682 |
1 | 125 (28.3) | 71 (30.2) | 54 (26.2) | |
2 | 68 (15.4) | 38 (16.2) | 30 (14.6) | |
>/=3 | 51 (11.6) | 25 (10.6) | 26 (12.6) | |
Victim of child abuse
| 106 (23.3) | 60 (25.4) | 46 (20.9) | 0.254 |
Victim of domestic abuse before pregnancy
| 159 (34.9) | 83 (35.2) | 76 (34.6) | 0.889 |
Victim of domestic abuse in pregnancy
| 86 (18.9) | 45 (19.1) | 41 (18.6) | 0.906 |
Smoking in pregnancy
| 79 (17.3) | 51 (21.6) | 28 (12.7) |
0.012
|
Alcohol use in pregnancy
| 77 (16.9) | 40 (17.0) | 37 (16.8) | 0.970 |
Substance use in pregnancy
| 61 (13.4) | 39 (16.5) | 22 (10.0) |
0.041
|
Self-harm in 2 years before pregnancy
| 67 (14.7) | 41 (17.4) | 26 (11.8) | 0.094 |
Number of days of acute care in 2 years before pregnancy,
| ||||
0 | 262 (57.5) | 121 (51.3) | 141 (64.1) |
0.021
|
1-33 | 67 (14.7) | 38 (16.1) | 29 (13.2) | |
34-79 | 63 (13.8) | 42 (17.8) | 21 (9.6) | |
83-537 | 64 (14.0) | 35 (14.8) | 29 (13.2) | |
Number of acute admissions in 2 years before pregnancy
| ||||
0 | 262 (57.5) | 121 (51.3) | 141 (64.1) |
0.025
|
1 | 127 (27.9) | 78 (33.1) | 49 (22.3) | |
2 | 38 (8.3) | 23 (9.8) | 15 (6.8) | |
>2 | 29 (6.4) | 14 (5.9) | 15 (6.8) | |
Time since last admission (years)
| ||||
1 year | 104 (53.6) | 65 (56.5) | 39 (49.4) | 0.326 |
2 years | 90 (46.4) | 50 (43.5) | 40 (50.6) | |
Highest HoNOS total adjusted score in 2 years before pregnancy, median (range)
2
| 12 (0–36) | 12 (0–36) | 12 (0–28) | 0.768 |
Medication
Medication
|
90 days pre pregnancy, N (%)
|
1
st
trimester, N (%)
| ||||
---|---|---|---|---|---|---|
Whole sample
|
Non-affective
|
Affective
|
Whole sample
|
Non-affective
|
Affective
| |
N = 450
|
N = 234
|
N = 216
|
N = 445
|
N = 232
|
N = 213
| |
No regular medication
| 126 (28.0) | 61 (26.1) | 65 (30.1) | 133 (29.9) | 65 (28.0) | 68 (31.9) |
Antipsychotics
| 255 (56.7) | 160 (68.4) | 95 (44.0) | 247 (55.5) | 158 (68.1) | 89 (41.8) |
Olanzapine | 98 (21.8) | 52 (22.2) | 46 (21.3) | 97 (21.8) | 53 (22.8) | 44 (20.7) |
Risperidone | 56 (12.4) | 37 (15.8) | 19 (8.8) | 52 (11.7) | 36 (15.2) | 16 (7.5) |
Aripiprazole | 45 (10.0) | 40 (17.1) | 5 (2.3) | 39 (8.8) | 34 (14.7) | 5 (2.4) |
Quetiapine | 35 (7.8) | 14 (6.0) | 21 (9.7) | 29 (6.5) | 11 (4.7) | 18 (8.5) |
Haloperidol | 16 (3.6) | 8 (3.4) | 8 (3.7) | 23 (5.2) | 17 (7.3) | 6 (2.8) |
Trifluoperazine | 8 (1.8) | 6 (2.6) | <5 | 9 (2.0) | 7 (3.0) | <5 |
Chlorpromazine | <5 | <5 | <5 | 7 (1.6) | <5 | <5 |
Flupenthixol | 8 (1.8) | 8 (3.4) | 0 | 8 (1.8) | 8 (3.5) | 0 |
Other
1
| 24 (5.3) | 18 (7.7) | 6 (2.8) | 23 (5.2) | 18 (7.8) | 5 (2.4) |
Mood stabilisers
| 82 (18.2) | 21 (9.0) | 61 (28.2) | 74 (16.6) | 18 (7.8) | 56 (26.3) |
Sodium Valproate | 41 (9.1) | 15 (6.4) | 26 (12.0) | 34 (7.6) | 13 (5.6) | 21 (9.9) |
Lithium | 24 (5.3) | <5 | 22 (10.2) | 21 (4.7) | <5 | 20 (9.4) |
Lamotrigine | 11 (2.4) | <5 | 8 (3.7) | 12 (2.7) | <5 | 9 (4.2) |
Carbamazepine/Topimarate | 9 (2.0) | <5 | 6 (2.8) | 9 (2.0) | <5 | 6 (2.8) |
Antidepressants
| 107 (23.8) | 39 (16.7) | 68 (31.5) | 103 (23.2) | 37 (16.0) | 66 (31.0) |
Citalopram/ Escitalopram | 25 (5.6) | 11 (4.7) | 14 (6.5) | 28 (6.3) | 11 (4.7) | 17 (8.0) |
Fluoxetine | 28 (6.2) | 7 (3.0) | 21 (9.7) | 25 (5.6) | 8 (3.5) | 17 (8.0) |
Sertraline | 15 (3.3) | 8 (3.4) | 7 (3.2) | 17 (3.8) | 9 (3.9) | 8 (3.8) |
Venlafaxine | 18 (4.0) | 5 (2.1) | 13 (6.0) | 16 (3.6) | 5 (2.2) | 11 (5.2) |
Mirtazepine | 15 (3.3) | <5 | 11 (5.1) | 11 (2.5) | <5 | 7 (3.3) |
Other
2
| 16 (3.6) | 7 (3.0) | 9 (4.2) | 17 (3.8) | 5 (2.2) | 12 (5.6) |
Polypharmacy*
| ||||||
2 agents | 104 (23.1) | 49 (20.9) | 55 (25.5) | 97 (21.8) | 49 (21.1) | 48 (22.5) |
>2 agents | 31 (6.9) | 13 (5.6) | 18 (8.3) | 33 (7.4) | 13 (5.6) | 17 (8.0) |
Anxiolytics
3
| 40 (7.5) | 34 (6.5) | ||||
Lorazepam | 13 (2.9) | 9 (3.9) | 4 (1.9) | 9 (2.0) | 5 (2.2) | <5 |
Diazepam | 10 (2.2) | <5 | 8 (3.7) | 8 (1.8) | <5 | 5 (2.4) |
Other
3
| 14 (3.1) | 7 (3.0) | 7 (3.2) | 12 (2.7) | <5 | 8 (3.8) |
Sedatives
| 35 (7.8) | 15 (6.4) | 20 (9.3) | 37 (8.3) | 16 (6.9) | 21 (9.9) |
Promethazine | 15 (3.3) | 8 (3.4) | 7 (3.2) | 21 (4.7) | 10 (4.3) | 11 (5.2) |
Zopiclone/zolpidem | 23 (5.1) | 9 (3.9) | 14 (6.5) | 24 (5.4) | 9 (3.9) | 15 (7.0) |
Side effects medication
| ||||||
Procyclidine | 18 (4.0) | 10 (4.3) | 8 (3.7) | 14 (3.2) | 9 (3.9) | 5 (2.4) |
Whole sample
|
Non-affective psychosis
|
Affective SMI
| |
---|---|---|---|
Antipsychotics |
N = 247
|
N = 158
|
N = 89
|
Switched | 28 (11.3) | 21 (13.3) | 7 (7.9) |
Stopped | 59 (24.0) | 33 (21.9) | 26 (29.2) |
Stopped or switched | 84 (34.0) | 53 (33.5) | 31 (34.8) |
Mood stabilisers |
N = 74
|
N = 18
|
N = 56
|
Switched | <5 | 0 | <5 |
Stopped | 36 (48.7) | 9 (50.0) | 27 (48.2) |
Stopped or switched | 37 (50.0) | 9 (50.0) | 28 (50.0) |
Antidepressants |
N = 103
|
N = 37
|
N = 66
|
Switched | <5 | <5 | <5 |
Stopped | 27 (26.2) | 7 (18.9) | 20 (30.3) |
Stopped or switched | 30 (29.1) | 9 (24.3) | 21 (31.8) |
Regular medication |
N = 312
|
N = 167
|
N = 145
|
Switched | 32 (10.3) | 23 (13.9) | 9 (6.2) |
Stopped | 98 (31.4) | 42 (25.2) | 56 (38.6) |
Stopped or switched | 125 (40.1) | 63 (37.7) | 62 (42.8) |